StreetAlpha
13F holdings · Q3 2026

Saturn V Capital Management

Austin, TX · files as Saturn V Capital Management LP
Know the moment Saturn V Capital Management filesYou follow Saturn V Capital Management An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1964437

Saturn V Capital Management reported 24 stocks worth $683M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are AMLX (19.1%), ABVX (7.7%) and IMMX (7.1%). Compared with Q2 2026, the fund opened new positions in RARE, ERAS and LTGO, added to ABVX, PHVS and CELC, trimmed AMLX, PCVX and JAZZ and sold out of IVVD and OVID.

Latest filing: what Saturn V Capital Management did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
3 new13 added6 trimmed2 sold outBought about $86M · sold about $24.9M
New 3
Added 13
See all 13 →
Trimmed 6
See all 6 →
Sold out 2

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$683M−2.1% vs last quarter
Stocks held243 new · 2 sold out
Top 5 weight46.7%fairly concentrated
Turnover16%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
AMLX
Amylyx Pharmaceuticals Inc
$130M19.1%4.5M−153K (−3%)8 of 8
2
ABVX
Abivax SA
$52.4M7.7%529K+10K (+2%)8 of 8
3
IMMX
Immix Biopharma Inc
$48.5M7.1%4.7MNo change4 of 8
4
PHVS
Pharvaris N V
$44.2M6.5%1.4M+80K (+6%)5 of 8
5
PCVX
Vaxcyte Inc
$43.9M6.4%772K−81K (−9%)8 of 8
6
CELC
Celcuity Inc
$40.9M6.0%514K+144K (+39%)8 of 8
7
IRON
Disc Medicine Inc
$40.1M5.9%613K+88K (+17%)8 of 8
8
CADL
Candel Therapeutics Inc
$36.3M5.3%3.5M+173K (+5%)3 of 8
9
JAZZ
Jazz Pharmaceuticals PLC
$34.8M5.1%150K−11K (−7%)6 of 8
10
MNPR
Monopar Therapeutics Inc
$24.9M3.6%312K+374 (+0%)5 of 8
🔒 14 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
IVVD
Invivyd Inc
$7.3M8.4M
OVID
Ovid Therapeutics Inc
$1.8M663K

Reported value

last 8 quarters
$255MQ4 '24
$198MQ1 '25
$247MQ2 '25
$456MQ3 '25
$545MQ4 '25
$552MQ1 '26
$697MQ2 '26
$683MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Saturn V Capital Management 13F FAQ

What does Saturn V Capital Management own?

Saturn V Capital Management reported 24 stocks worth $683M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are AMLX (19.1%), ABVX (7.7%) and IMMX (7.1%). The table above lists every position in the filing (the top 10 without an account).

What did Saturn V Capital Management buy and sell in Q3 2026?

Compared with Q2 2026: 3 new positions, 13 added to, 6 trimmed and 2 sold out. New positions include RARE, ERAS and LTGO. It sold all of IVVD and OVID.

When will Saturn V Capital Management file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Saturn V Capital Management's portfolio worth?

The Q3 2026 filing reports $683M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.